IP Library Granted Patent US 11,136,312
Granted Patent B2
US 11,136,312 · App. 16/613,086 · Granted Oct 5, 2021

3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof

Inventors: Kenneth A. Witt (Edwardsville, IL); Albert M. Crider (Maryville, IL); William Neumann (St. Louis, MO); Audrey Hospital (Robbinsville, NJ); Karin Sandoval (Edwardsville, IL); Maria Kontoyianni (Glen Carbon, IL)
Assignee: Board of Trustees of the Southern Illinois University
C07D403/14C07D233/64C07D401/12C07D401/14C07D403/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,136,312
App. No.
16/613,086
Granted
Oct 5, 2021
Kind
B2
Abstract

The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.

Claims (41)

1. A compound of Formula (I):

wherein

are independently a single bond or is absent;

A is C(H) or N;

B and C are independently C(H), N, N(H), O, or S, provided that when B or C is C(H) or N, is a single bond, and when B or C is N(H), O, or S, is absent, and further provided that at least one of B and C is N, N(H), O, or S;

R 1 and R 7 are independently hydrogen, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted cycloalkyl, or substituted or unsubstituted fused ring system;

R 2 is substituted or unsubstituted C 1 -C 6 alkyl;

R 3 , R 4 , and R 5 are independently hydrogen, F, Cl, Br, I, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted amine, thiosulfinate, thiosulfonate, thioamide, sulfimide, sulfoximide, sulfonediimine, or sulfur halide;

R 6 and R 8 are independently substituted or unsubstituted C 1 -C 2 alkyl; and

R 9 is a substituted or unsubstituted C 1 -C 3 alkyl;

with the proviso that when R 9 is C 2 alkyl, R 7 is not a 3,4-dichlorobenzene.

2. The compound of claim 1 , wherein A, B, and C are N.

3. A compound of Formula (I):

wherein

are independently a single bond or is absent;

A is C(H) or N;

B and C are independently C(H), N, N(H), O, or S, provided that when B or C is C(H) or N, is a single bond, and when B or C is N(H), O, or S, is absent, and further provided that at least one of B and C is N, N(H), O, or S;

R 1 and R 7 are independently substituted or unsubstituted aryl or substituted or unsubstituted fused ring system;

R 2 is substituted or unsubstituted C 1 -C 6 alkyl;

R 3 , R 4 , and R 5 are independently hydrogen, F, Cl, Br, I, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted amine, thiosulfinate, thiosulfonate, thioamide, sulfimide, sulfoximide, sulfonediimine, or sulfur halide;

R 6 and R 8 are independently hydrogen, F, Cl, Br, I, substituted or unsubstituted C 1 -C 6 alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted cycloalkyl; and

R 9 is a substituted or unsubstituted C 1 -C 3 alkyl;

with the proviso that when R 9 is C 2 alkyl, R 7 is not a 3,4-dichlorobenzene.

4. The compound of claim 3 , wherein R 1 is substituted or unsubstituted fused ring system.

5. The compound of claim 4 , wherein R 1 is substituted or unsubstituted indole.

6. The compound of claim 3 , wherein R 1 is substituted or unsubstituted aryl.

7. The compound of claim 6 , wherein R 7 is

wherein R 10 , R 11 , R 12 , R 13 , and R 14 is independently hydrogen, F, Cl, Br, I, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted amine, SO 2 CH 3 , thiosulfinate, thiosulfonate, thioamide, sulfimide, sulfoximide, sulfonediimine, or sulfur halide.

8. The compound of claim 7 , wherein R 10 , R 11 , R 12 , R 13 , and R 14 is independently hydrogen, F, Cl, Br, I, CF 3 , OCH 3 , OCH 2 (C 6 H 4 ), SO 2 CH 3 , or OCF 3 .

9. The compound of claim 1 , wherein R 2 is substituted or unsubstituted C 1 -C 3 alkyl.

10. The compound of claim 9 , wherein R 2 is substituted or unsubstituted propyl.

11. The compound of claim 10 , wherein R 2 is unsubstituted propyl.

12. The compound of claim 1 , wherein R 3 , R 4 , and R 5 are independently hydrogen, F, Cl, Br, I, or substituted or unsubstituted alkyl.

13. The compound of claim 12 , wherein R 3 , R 4 , and R 5 are hydrogen.

14. The compound of claim 1 , wherein R 9 is methyl.

15. The compound of claim 1 , wherein R 9 is ethyl.

16. A compound selected from the group consisting of:

17. The compound of claim 3 , wherein A, B, and C are N.

18. The compound of claim 3 , wherein R 2 is substituted or unsubstituted C 1 -C 3 alkyl.

19. The compound of claim 1 , wherein R 1 and R 7 are independently substituted or unsubstituted aryl or substituted or unsubstituted fused ring system.

20. The compound of claim 3 , wherein R 6 and R 8 are independently substituted or unsubstituted C 1 -C 3 alkyl.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 11, 2023
From: SOUTHERN ILLINOIS UNIV AT EDWARDSVILLE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064857/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2020
From: WITT, KENNETH A.; CRIDER, ALBERT M.; NEUMANN, WILLIAM; HOSPITAL, AUDREY; SANDOVAL, KARIN; KONTOYIANNI, MARIA
To: BOARD OF TRUSTEES OF THE SOUTHERN ILLINOIS UNIVERSITY
Reel/Frame 054345/0915 →
Continuity (2)
Provisional Application 62505384 · May 12, 2017
Related Publication 20200165230A1 · May 28, 2020